Status:
COMPLETED
Diagnoses Associated With Persistent Elevation of Creatine Kinase
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Creatine Kinase
Muscular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Serum creatinine kinase (CK) level varies with age, gender, race and physical activity. For these reasons there is no normal serum CK level. Many pathological situations cause hyperCKemia, such as neu...
Eligibility Criteria
Inclusion
- patients hospitalised in a ward of internal medicin
- having a persistent elevation of serum creatine kinase \>3 times the upper normal laboratory value, repeated for 2 times
Exclusion
- known neuro-muscular disease causing elevation of creatine kinase
- evident post-traumatic cause responsible for the elevation of creatine kinase
- incomplete medical records
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 24 2021
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT04838509
Start Date
May 1 2021
End Date
June 24 2021
Last Update
June 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Nancy, France, 54000